StockData
NRC Health logo

NRC Health (NRC) stock

NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3078% above fair value
$25.89−0.44 (-1.69%)

Close on Nov 17, 2026Market cap $572.57MP/E –Yield 2.01%

NRC Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

NRC Health's price to sales ratio was 4.2× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 1.8× to 7.6×, with a median of 4.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.2×+1.2
2025Dec 31, 20253.1×+0.2
2024Dec 31, 20242.9×−3.7
2023Dec 29, 20236.5×+0.5
2022Dec 30, 20226.1×−1.2
2021Dec 31, 20217.3×−0.9
2020Dec 31, 20208.3×−4.8
2019Dec 31, 201913.0×+5.1
2018Dec 31, 20187.9×+6.5
2013Jul 31, 20131.4×−0.7
2012Dec 31, 20122.1×−0.3
2011Dec 30, 20112.4×−0.5
2010Dec 31, 20102.9×–

More NRC Health figures

See a number that looks wrong?